the discovery and development of liraglutide and semaglutide PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: The discovery and development of

The Legal Battle Behind the Weight Loss Drug Ozempic lawsuit cases center on allegations that Novo Nordisk, the manufacturer of Ozempic (semaglutide), failed to adequately warn patients and prescribing physicians about the drug's potential to cause severe gastrointestinal conditions, most notably a condition called gastroparesis, sometimes described in plaintiff filings as "stomach paralysis." Gastroparesis is a condition in which the stomach cannot empty itself properly

Weight loss itself can improve mental health, and the metabolic improvements from these medications may have neuroprotective benefits

Weight-loss use is not appropriate during pregnancy, and both are not recommended in severe gastroparesis

Just complete a brief medical intake so a licensed provider can determine whether this treatment is appropriate for your needs

Discard unused medication after the BUD, even if it appears unchanged